Piper Sandler Companies (PIPR) Q1 2026 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call reveals strong financial performance with significant revenue growth, particularly in corporate financing and advisory services. Despite some sector-specific slowdowns, the company maintains a positive outlook. The Q&A highlights uncertainties in M&A and equity markets, but the overall sentiment remains optimistic. A 4-for-1 stock split is a positive catalyst. Given the company's market cap, the stock price is likely to see a moderate positive movement of 2% to 8% over the next two weeks.
Key Financial Performance
Adjusted Net Revenues $470 million, a 22% increase year-over-year, driven by a 30% increase in Corporate Investment Banking revenues, strong Advisory Services, and robust Corporate Financing activity.
Operating Margin 20%, reflecting strong revenue growth and disciplined expense management.
Adjusted EPS $1, reflecting strong financial performance.
Corporate Investment Banking Revenues $324 million, up 30% year-over-year, driven by robust corporate financing activity and solid contributions across advisory services.
Advisory Revenues $251 million, up 16% year-over-year, driven by strong performance in Healthcare and Financial Services, and contributions from Services, Industrials, and Energy teams.
Corporate Financing Revenues $73 million, up 122% year-over-year, driven by strong equity issuance for biopharma companies and Healthcare sector activity.
Municipal Financing Revenues $24 million, down 9% year-over-year, due to market conditions.
Equity Brokerage Revenues $60 million, up 11% year-over-year, driven by higher trading volumes and increased hedging activity.
Fixed Income Revenues $50 million, up 6% year-over-year, supported by balance sheet restructuring trades and diversification of product capabilities.
Non-Compensation Expenses $86 million, up 15% year-over-year, partly due to an $8.5 million litigation-related expense. Excluding this, the increase was 4% year-over-year, driven by higher underwriting expenses.
Compensation Ratio 61.6%, an improvement of 90 basis points year-over-year, reflecting increased net revenues and operating discipline.
Income Tax Expense $7 million reduction due to tax benefits from restricted stock awards, resulting in an effective tax rate of 23.4%. Excluding these benefits, the effective tax rate was 30.8%.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
Healthcare franchise: Produced exceptionally strong revenues driven by medtech and biopharma teams, as well as contributions from Healthcare IT and Services.
Corporate Financing: Revenues reached $73 million, up 122% year-over-year, with $14 billion raised for corporate clients. Activity led by Healthcare team with 23 equity deals priced.
U.S. medtech M&A: Ranked as the top adviser based on the number of announced deals.
U.S. bank M&A: Ranked as the #1 adviser based on deal value announced during the quarter.
Biopharma sector: Ranked as the #2 investment bank based on the number of book-run deals.
Investment Banking Managing Directors: Achieved the highest number in firm history with 192 MDs. Promoted 6 bankers and hired 3 MDs to strengthen advisory capabilities.
Equity Brokerage business: Achieved record first quarter revenues of $60 million, an 11% increase year-over-year, driven by higher volatility and increased trading volumes.
Core strategy: Focused on advising clients with deep expertise and providing a comprehensive suite of capital market solutions.
Talent development: Prioritized internal talent development and hiring talented partners to strengthen product and sector teams.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Market Conditions: The timing of transactions may be influenced by market conditions, which could impact advisory revenues.
Macroeconomic Environment: The near-term macroeconomic environment remains uncertain, posing risks to the company's core strategy and growth plans.
Equity Brokerage Volatility: While volatility drove record revenues in Equity Brokerage, it is expected to decline in the second quarter, impacting revenues.
Fixed Income Business Challenges: Ongoing geopolitical developments and day-to-day volatility have reduced client activity, leading to a slow start in the second quarter.
Litigation Expense: An $8.5 million litigation-related expense was incurred due to a pending settlement of a California lawsuit filed in 2014, impacting non-compensation costs.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Advisory Revenues: Looking ahead, industry and product teams are busy advising clients and pipelines remain strong. However, the timing of these transactions may be influenced by market conditions. Second quarter advisory revenues are expected to be similar to the first quarter.
Corporate Financing Revenues: Second quarter corporate financing revenues are expected to decline from a strong first quarter.
Public Finance Revenues: Pipelines are strong with clients looking to access the market. Second quarter revenues are anticipated to improve modestly from the first quarter, aligning with typical seasonality.
Equity Brokerage Revenues: Second quarter revenues are expected to decline from the record first quarter levels, as results will continue to be correlated with market volatility and trading volumes.
Fixed Income Outlook: The near-term fixed income outlook remains challenging. The second quarter has experienced a slow start as ongoing geopolitical developments are keeping many clients on the sidelines.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
Dividends Paid: During the first quarter, $101 million or $1.45 per share was paid to shareholders through quarterly and special cash dividends.
Quarterly Cash Dividend Increase: The Board approved a quarterly cash dividend of $0.20 per share, a 14% increase from the previous quarterly cash dividend. This dividend will be paid on June 12 to shareholders of record as of May 29.
Share Repurchase: Approximately 884,000 shares of common stock were repurchased for $70 million during the first quarter. This repurchase offset a significant portion of the share count dilution from this year's annual grants.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:Has the upward trend in bank M&A activity slowed, and how does recent rate volatility impact the Bank Hedging business and Fixed Income?
A:Chad Abraham noted that bank M&A activity has slowed slightly, particularly for larger transactions, though smaller transactions are still occurring. Debbra Schoneman added that while there is increased activity in bank hedging, volatility makes it challenging for banks to determine their positioning.
Q:How sustainable is the equity capital markets activity, particularly in Healthcare?
A:Chad Abraham stated that while Q1 was strong, particularly in Healthcare, the outsized market share performance is not sustainable in Q2. He noted that the biotech market trades differently and remains open, but overall sustainability is uncertain.
Q:Which sectors are experiencing the biggest slowdown in deal activity, and how long might this moderation persist?
A:Chad Abraham mentioned that the slowdown varies by sector, with banks and sponsors showing reduced urgency. Healthcare and Medtech had strong Q1 performances that are hard to repeat. He expects the market to remain stable but not accelerating.
Q:What is the outlook for Software M&A amidst concerns about AI disruption and SaaS market challenges?
A:Chad Abraham explained that while Technology is a smaller focus for the company, Q1 saw decent performance. However, larger deals are slowing due to cautious behavior, lower valuations, and AI-related uncertainties. He expects cautious performance in Tech and Software for the year.
Q:What is the contribution of non-M&A businesses like private capital and restructuring to the overall outlook?
A:Chad Abraham highlighted that Debt Capital Markets Advisory performed well in Q1, while restructuring and private capital were steady. He is optimistic about private capital advisory's growing contribution across industry teams.
Q:What factors are affecting fixed income revenues, and what needs to change to bring clients off the sidelines?
A:Debbra Schoneman stated that extreme market volatility, driven by interest rates and geopolitical factors, is the main issue. A sustained reduction in volatility is needed to improve activity. Bank M&A slowdowns also impact opportunities.
Q:What is the outlook for the company's compensation ratio and its ability to drive leverage?
A:Debbra Schoneman noted that the company is operating at the low end of its guided range (61.5%-62.5%) and aims to maintain this level. While opportunities for leverage exist, they may be modest due to the variable compensation model.
Q:How did Advisory pipeline activity transition from winter to spring this year compared to normal years?
A:Chad Abraham stated that Q1 was strong despite seasonal challenges, with record performance following a strong Q4. The transition was typical, with no extraordinary changes.
Q:What factors are needed for markets to return to an upward slope?
A:Chad Abraham identified stability in stock prices, resolution of global macroeconomic issues, and confidence in valuations as key factors. He noted that sponsors are pitching but decisions to launch and transact depend on market certainty.
Q:Review of Unclear Management Responses
A:Management avoided providing a clear answer on the sustainability of equity capital markets activity, particularly in Healthcare, and the outlook for Software M&A amidst AI concerns. Responses were vague and lacked specific data or detailed insights.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
Activity Healthcare
Advisory Group
Advisory start
Asset subsectors
Banking record
Brokerage business
Brokerage income
Brokerage volatility
Chad start
Corporate Financing
Deb Public
Debt Capital
Development
Energy
Equity Brokerage
Financial Services
Financing revenue
Piper Sandler
Sandler Conference
adviser
bank transaction
biopharma
client activity
client pipeline
contribution
desk
market condition
market volatility
medtech
number
relationship
research
trading volume
volatility trading
PIPR Transcript
Piper Sandler Companies (PIPR) Q1 2026 Earnings Call Transcript
Positive5-1
The earnings call reveals strong financial performance with significant revenue growth, particularly in corporate financing and advisory services. Despite some sector-specific slowdowns, the company maintains a positive outlook. The Q&A highlights uncertainties in M&A and equity markets, but the overall sentiment remains optimistic. A 4-for-1 stock split is a positive catalyst. Given the company's market cap, the stock price is likely to see a moderate positive movement of 2% to 8% over the next two weeks.
Piper Sandler Companies (PIPR) Q4 2025 Earnings Call Transcript
Positive2-6
The earnings call reveals strong financial performance with record high revenues, improved compensation ratios, and significant shareholder returns. The Q&A highlights robust sponsor business, strategic capital allocation, and growth in PCA and debt capital advisory. Despite cautious ECM outlook and vague responses on bank M&A, the overall sentiment is positive with strong advisory and municipal financing pipelines. The company's market cap suggests moderate volatility, supporting a positive stock price movement of 2% to 8% over the next two weeks.
Piper Sandler Companies (PIPR) Q3 2025 Earnings Call Transcript
Positive10-31
The earnings call highlights strong financial performance, including a 29% YoY increase in net revenues, improved operating margins, and higher EPS. The company also announced a cash dividend and a share repurchase program. Despite some concerns in the Q&A about government shutdown risks and management's lack of specific guidance, the overall sentiment is positive due to strong revenue growth, optimistic guidance, and strategic investments in tech and M&A sectors.
Piper Sandler Companies (PIPR) Q2 2025 Earnings Call Transcript
Positive8-1
The earnings call reveals strong financial performance, with increased operating margins, adjusted EPS, and significant growth in advisory, municipal financing, and fixed income revenues. Despite challenges in corporate financing, other areas show robust activity. The Q&A indicates optimism in bank M&A and IPO markets. The company's confidence in its investment banking strategy and shareholder returns further supports a positive outlook. Considering the market cap, the stock is likely to experience a modest positive movement of 2% to 8% over the next two weeks.
PIPR Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
